Clinical trial · Interventional
Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer
Evaluation of the Efficacity of Lanreotide LP 90 mg to Minimized the Lymphorrhea Post Axillary Lymphadenectomy in Breast Cancer
NCT00630695CI-TRIAL-00006064completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Injection the day before surgery of 90 mg of Lanreotide LP sub-cutaneously or placebo. Evaluation of the lymphorrhea in the 2 arms of the study
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphocele | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lanreotide LP 90 | Drug | — | UNRESOLVED |
| Placebo lanreotide | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 1
- description
- Lanreotide LP 90
- interventionNames
- Drug: Lanreotide LP 90
- type
- PLACEBO_COMPARATOR
- label
- 2
- interventionNames
- Drug: Placebo lanreotide
Primary outcomes (1)
- measure
- Quantity of lymph collected by the drain
- timeFrame
- D4 post operativly
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient (\> 18 years), * Patient undergoing an axillary lymphadenectomy for breast cancer * Patient giving her agreement after being informed Exclusion Criteria: * Patients that don't understand the trial * Type 2 diabetic patients * Cyclosporine treatment * Biliary lithiasis * Pregnancy or breast feeding * Allergic reaction to Lanréotide or same class treatments * Patient included in another trial within the last 30 days
References
Publications (0)
Data not yet available
No reference posted for this study.